Axe Compute Inc. (NASDAQ:AGPU)
| Market Cap | $65.01M-8.6% |
| Revenue (ttm) | $20.98M+2781.1% |
| Net Income | -$164.34M-94.9% |
| EPS | -$37.68+65.2% |
| Shares Out | 11.38M |
| PE Ratio | n/a |
| Forward PE | 7.61 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 308,064 |
| Open | $6.18 |
| Previous Close | $6.41 |
| Day's Range | $5.52 - $6.19 |
| 52-Week Range | $1.03 - $13.49 |
| Beta | 3.83 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Apr 1, 2027 |
About AGPU
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Axe Compute Inc. Stock Analysis — InsiderScore
Axe Compute Inc. scored higher than 33% of companies evaluated by InsiderBuying, and ranked 67th out of 93 stocks in the technology sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Axe Compute Inc. bought $98.3K of stock across 2 purchases in the last 90 days, the largest of them $54.4K.
The average purchase added about 37% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Apr 1, 2027Earnings report
$AGPU stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in AGPU holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AGPU's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AGPU Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New AGPU patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AGPU from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in AGPU
| VXFVanguard Extended Market ETF | $495.36K |
| IWCiShares Micro-Cap ETF | $181.63K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from AGPU’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 2026 earnings show strong 125% revenue surge driven by AI demand, with board appointment of experienced executive adding institutional credibility.
Recent Insider Activity
Insider Score Trend Over Time
-1.0 since Sep 17Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
